A Phase II Trial Evaluating the Safety and Effectiveness of the AastromReplicell System for Augmentation of Low-Dose Blood Stem Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703137

Related search